William A. Albright

Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA.

Falco Biotherapeutics BV operates as a biopharmaceutical company. It focuses on the development of (ElCams) engineered loop containing affinity molecules, a category of therapeutic, diagnostic, and prophylactic protein-based health care products to treat inflammation and infectious diseases. The company was founded in 2006 and is located in Amsterdam, The Netherlands

FlowMedica, Inc. develops intravascular systems and medical devices. The company's products include Benephit CV, PVSolo, PVMini, and XT Infusion systems. It also develops novel, proprietary, and minimally invasive intravascular systems for implementing Targeted Renal Therapy. The company was founded in 2002 and is headquartered in Fremont, CA.

Nexell Therapeutics, Inc. develops, manufactures and markets pharmaceutical therapies. Its cell therapy is used for the treatment of genetic blood disorders, autoimmune diseases, cancer, and regenerative medicine applications. The company is headquartered in Irvine, CA.

LocalMed, Inc. manufactures medical devices for interventional cardiology. It provides analysis & data on pharma biotech device & diagnostic company strategy & trends.The company was founded by Aaron V. Kaplan and is headquartered in Palo Alto, CA.

Xlumena, Inc. operates as a medical device company. The company was founded by Kenneth F. Binmoeller in 2004 and is headquartered in Mountain View, CA.